✦ LIBER ✦

Combined therapy with deferiprone and desferrioxamine successfully regresses severe heart failure in patients with β-thalassemia major

✍ Scribed by K.H. Wu; J.S. Chang; C.H. Tsai; C.T. Peng

Publisher: Springer
Year: 2004
Tongue: English
Weight: 184 KB
Volume: 83
Category: Article
ISSN: 0939-5555
DOI: 10.1007/s00277-003-0820-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combined therapy with desferrioxamine an

Combined therapy with desferrioxamine and deferiprone in beta thalassemia major patients with transfusional iron overload

✍ S. Daar; A. V. Pathare 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 102 KB

Prospective comparison on cardiac iron b

Prospective comparison on cardiac iron by MR in thalassemia major patients treated with combination deferipron-desferrioxamine versus deferipron and desferrioxamine in monoterapy

✍ Alessia Pepe; Antonella Meloni; Giuseppe Rossi; Maria Chiara Dell’Amico; Marcell 📂 Article 📅 2011 🏛 BioMed Central 🌐 English ⚖ 290 KB

A T2* MRI prospective survey on heart ir

A T2* MRI prospective survey on heart iron in thalassemia major patients treated with sequential deferiprone-desferrioxamine versus deferipron and desferrioxamine in monotherapy

✍ Alessia Pepe; Antonella Meloni; Giuseppe Rossi; Maria Chiara Dell’Amico; Luciano 📂 Article 📅 2011 🏛 BioMed Central 🌐 English ⚖ 284 KB

Pepe et al.: A T2\* MRI prospective survey on heart iron in thalassemia major patients treated with sequential deferipronedesferrioxamine versus deferipron and desferrioxamine in monotherapy.

A T2* MRI prospective survey on heart ir

A T2* MRI prospective survey on heart iron in thalassemia major patients treated with deferasirox versus deferiprone and desferrioxamine in monotherapy

✍ Alessia Pepe; Antonella Meloni; Giuseppe Rossi; Maria Chiara Dell’Amico; Anna Sp 📂 Article 📅 2011 🏛 BioMed Central 🌐 English ⚖ 292 KB

Pepe et al.: A T2\* MRI prospective survey on heart iron in thalassemia major patients treated with deferasirox versus deferiprone and desferrioxamine in monotherapy.